Joris Messens

Prof. Dr. Joris Messens

Vrije Universiteit Brussel
+1
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Cell Metabolism
Verified
Journal Article
Closed access
VPValeriy V. Pak
Valeriy V. Pak
DEDaria Ezeriņa
Daria Ezeriņa
OLOlga Lyublinskaya
Olga Lyublinskaya
BPBrandán Pedre
Brandán Pedre
Pyotr Tyurin-KuzminPyotr Tyurin-Kuzmin
Pyotr Tyurin-Kuzmin
VBVsevolod Belousov
Vsevolod Belousov

15 October 2010 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
JCJean-Francois Collet
Jean-Francois Collet
JMJoris Messens
Joris Messens
Thioredoxins are ubiquitous antioxidant enzymes that play important roles in many health-related cellular processes. As such, the fundamental knowledge of how these enzymes work is of prime importance for understanding cellular redox mechanisms and for laying the ground for the development of future therapeutic approaches. Over the past 40 years, a really impressive amount of data has been published on thioredoxins. Here, we review the most significant results that have contributed to our knowledge regarding the structure, the function, and the mechanism of these crucial enzymes. Antioxid. Redox Signal. 13, 1205–1216.

1 October 2017 in Redox Biology
Verified
Journal Article
Open access
Javier EgeaJavier Egea
Javier Egea
Isabel FabregatIsabel Fabregat
Isabel Fabregat
YFYves M. Frapart
Yves M. Frapart
PGPietro Ghezzi
Pietro Ghezzi
AGAgnes Görlach
Agnes Görlach
Andreas DaiberAndreas Daiber
Andreas Daiber
The European Cooperation in Science and Technology (COST) provides an ideal framework to establish multi-disciplinary research networks. COST Action BM1203 (EU-ROS) represents a consortium of researchers from different disciplines who are dedicated to providing new insights and tools for better understanding redox biology and medicine and, in the long run, to finding new therapeutic strategies to target dysregulated redox processes in various diseases. This report highlights the major achievements of EU-ROS as well as research updates and new perspectives arising from its members. The EU-ROS consortium comprised more than 140 active members who worked together for four years on the topics briefly described below. The formation of reactive oxygen and nitrogen species (RONS) is an established hallmark of our aerobic environment and metabolism but RONS also act as messengers via redox regulation of essential cellular processes. The fact that many diseases have been found to be associated with oxidative stress established the theory of oxidative stress as a trigger of diseases that can be corrected by antioxidant therapy. However, while experimental studies support this thesis, clinical studies still generate controversial results, due to complex pathophysiology of oxidative stress in humans. For future improvement of antioxidant therapy and better understanding of redox-associated disease progression detailed knowledge on the sources and targets of RONS formation and discrimination of their detrimental or beneficial roles is required. In order to advance this important area of biology and medicine, highly synergistic approaches combining a variety of diverse and contrasting disciplines are needed.

1 July 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
GRGoedele Roos
Goedele Roos
JMJoris Messens
Joris Messens

1 January 2013 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
GRGoedele Roos
Goedele Roos
NFNicolas Foloppe
Nicolas Foloppe
JMJoris Messens
Joris Messens
Many cellular functions involve cysteine chemistry via thiol–disulfide exchange pathways. The nucleophilic cysteines of the enzymes involved are activated as thiolate. A thiolate is much more reactive than a neutral thiol. Therefore, determining and understanding the p K a s of functional cysteines are important aspects of biochemistry and molecular biology with direct implications for redox signaling. Here, we describe the experimental and theoretical methods to determine cysteine p K a values, and we examine the factors that control these p K a s. Drawing largely on experience gained with the thioredoxin superfamily, we examine the roles of solvation, charge–charge, helix macrodipole, and hydrogen bonding interactions as p K a -modulating factors. The contributions of these factors in influencing cysteine p K a s and the associated chemistry, including the relevance for the reaction kinetics and thermodynamics, are discussed. This analysis highlights the critical role of direct hydrogen bonding to the cysteine sulfur as a key factor modulating the equilibrium between thiol S–H and thiolate S − . This role is easily understood intuitively and provides a framework for biochemical functional insights. Antioxid. Redox Signal. 18, 94–127.

5 March 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PSP Stassens
P Stassens
PBP W Bergum
P W Bergum
YGYannick Gansemans
Yannick Gansemans
LJL Jespers
L Jespers
YLY Laroche
Y Laroche
GVG P Vlasuk
G P Vlasuk
Hookworms are hematophagous nematodes that infect a wide range of mammalian hosts, including humans. There has been speculation for nearly a century as to the identity of the anticoagulant substances) used by these organisms to subvert host hemostasis. Using molecular cloning, we describe a family of potent small protein (75-84 amino acids) anticoagulants from the hookworm Ancylostoma caninum termed AcAP (A. caninum anticoagulant protein). Two recombinant AcAP members (AcAP5 and AcAP6) directly inhibited the catalytic activity of blood coagulation factor Xa (fXa), while a third form (AcAPc2) predominantly inhibited the catalytic activity of a complex composed of blood coagulation factor VIIa and tissue factor (fVIIa/TF). The inhibition of fVIIa/TF was by a unique mechanism that required the initial formation of a binary complex of the inhibitor with fXa at a site on the enzyme that is distinct from the catalytic center (exo-site). The sequence of AcAPc2 as well as the utilization of an exo-site on fXa distinguishes this inhibitor from the mammalian anticoagulant TFPI (tissue factor pathway inhibitor), which is functionally equivalent with respect to fXa-dependent inhibition of fIIa/TF. The relative sequence positions of the reactive site residues determined for AcAP5 with the homologous regions in AcAP6 and AcAPc2 as well as the pattern of 10 cysteine residues present in each of the inhibitors suggest that the AcAPs are distantly related to the family of small protein serine protease inhibitors found in the nonhematophagous nematode Ascaris lumbricoides var. suum.